Literature DB >> 16945995

Neurosphere assays: growth factors and hormone differences in tumor and nontumor studies.

Kaisorn Chaichana1, Grettel Zamora-Berridi, Joaquin Camara-Quintana, Alfredo Quiñones-Hinojosa.   

Abstract

The "no new neuron" dogma that the brain is quiescent throughout adult life has been challenged by the discovery of cells with stem cell-like qualities of self-renewal and multipotency in the subventricular zone of the lateral ventricles and the dentate gyrus of the hippocampus in adults. This self-renewing capacity also makes these neural stem cells a possible source of brain tumors, which was supported by the discovery of self-sustaining brain tumor stem-like cells in cancers such as glioblastoma multiforme. Neurosphere assays are the standard for studying these stem-like cells in both normal and cancer tissues. Despite the importance of these assays, there is no standardized protocol to allow for a comparison of results because several studies use different growth factors and hormones at different concentrations. The primary objective of this study is to review the literature for both nontumor and tumor studies to assess their respective neurosphere assay components. We found significant variation in assay components, namely hormones and growth factors, as well as their respective concentrations. This illustrates the need for a standardized protocol to allow proper comparison among studies and a better assessment of the effects of different factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945995     DOI: 10.1634/stemcells.2006-0399

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  37 in total

Review 1.  The cancer stem cell paradigm: a new understanding of tumor development and treatment.

Authors:  Johnathan D Ebben; Daniel M Treisman; Michael Zorniak; Raman G Kutty; Paul A Clark; John S Kuo
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

2.  Intra-operatively obtained human tissue: protocols and techniques for the study of neural stem cells.

Authors:  Kaisorn L Chaichana; Hugo Guerrero-Cazares; Vivian Capilla-Gonzalez; Grettel Zamora-Berridi; Pragathi Achanta; Oscar Gonzalez-Perez; George I Jallo; Jose Manuel Garcia-Verdugo; Alfredo Quiñones-Hinojosa
Journal:  J Neurosci Methods       Date:  2009-03-05       Impact factor: 2.390

Review 3.  Stem cells for brain repair in neonatal hypoxia-ischemia.

Authors:  L Chicha; T Smith; R Guzman
Journal:  Childs Nerv Syst       Date:  2013-11-01       Impact factor: 1.475

Review 4.  Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas.

Authors:  Kaisorn L Chaichana; Leon Pinheiro; Henry Brem
Journal:  Ther Deliv       Date:  2015-03

5.  Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models.

Authors:  Mari Kogiso; Lin Qi; Frank K Braun; Sarah G Injac; Linna Zhang; Yuchen Du; Huiyuan Zhang; Frank Y Lin; Sibo Zhao; Holly Lindsay; Jack M Su; Patricia A Baxter; Adekunle M Adesina; Debra Liao; Mark G Qian; Stacey Berg; Jodi A Muscal; Xiao-Nan Li
Journal:  Clin Cancer Res       Date:  2018-02-20       Impact factor: 12.531

6.  IL-13Rα2-Targeted Therapy Escapees: Biologic and Therapeutic Implications.

Authors:  Van Nguyen; Jesse M Conyers; Dongqin Zhu; Denise M Gibo; Jay F Dorsey; Waldemar Debinski; Akiva Mintz
Journal:  Transl Oncol       Date:  2011-12-01       Impact factor: 4.243

Review 7.  The Unexpected Roles of Aurora A Kinase in Gliobastoma Recurrences.

Authors:  Estelle Willems; Arnaud Lombard; Matthias Dedobbeleer; Nicolas Goffart; Bernard Rogister
Journal:  Target Oncol       Date:  2017-02       Impact factor: 4.493

8.  Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds.

Authors:  Fangrui Wu; Hong Jiang; Baisong Zheng; Mari Kogiso; Yuan Yao; Chao Zhou; Xiao-Nan Li; Yongcheng Song
Journal:  J Med Chem       Date:  2015-08-26       Impact factor: 7.446

9.  EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition.

Authors:  Yong Zhang; Shao-Xiang Wang; Ji-Wei Ma; Hai-Ying Li; Jie-Cheng Ye; Si-Ming Xie; Bin Du; Xue-Yun Zhong
Journal:  J Neurooncol       Date:  2014-08-31       Impact factor: 4.130

10.  Human embryonic and neuronal stem cell markers in retinoblastoma.

Authors:  Gail M Seigel; Abigail S Hackam; Arupa Ganguly; Lorrie M Mandell; Federico Gonzalez-Fernandez
Journal:  Mol Vis       Date:  2007-06-08       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.